Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 0.12.

  • Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio rose 2734494.14% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year increase of 2734494.14%. This contributed to the annual value of 0.0 for FY2024, which is 2779.64% down from last year.
  • Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio amounted to 0.12 in Q3 2025, which was up 2734494.14% from 0.0 recorded in Q2 2025.
  • Viridian Therapeutics, Inc.\DE's 5-year Asset Utilization Ratio high stood at 0.12 for Q3 2025, and its period low was 0.0 during Q4 2024.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio had a median value of 0.0 in 2023 and averaged 0.01.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio plummeted by 9201.66% in 2021 and then surged by 2734494.14% in 2025.
  • Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio stood at 0.01 in 2021, then plummeted by 70.98% to 0.0 in 2022, then tumbled by 81.06% to 0.0 in 2023, then plummeted by 47.97% to 0.0 in 2024, then surged by 30513.65% to 0.12 in 2025.
  • Its last three reported values are 0.12 in Q3 2025, 0.0 for Q2 2025, and 0.0 during Q1 2025.